Four Molecular Subtypes of Colorectal Cancer and Their Precursor Lesions

被引:4
|
作者
Kang, Gyeong Hoon [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea
关键词
ISLAND METHYLATOR PHENOTYPE; POPULATION-BASED SAMPLE; SPORADIC COLON-CANCER; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; SERRATED POLYPS; LYNCH SYNDROME; CLINICOPATHOLOGICAL FEATURES; CPG-ISLANDS; MUTATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-In addition to chromosomal instability and microsatellite instability (MSI), a third pathway, epigenetic instability, has been implicated in progression to colorectal carcinogenesis. CpG island methylator phenotype (CIMP) refers to a subset of colorectal cancers (CRCs) that occur through the epigenetic instability pathway and that are characterized by widespread hypermethylation of promoter CpG island loci, resulting in the inactivation of several tumor suppressor genes or tumor-related genes. Colorectal cancers can be classified into 4 molecular subtypes according to their CIMP and MSI statuses: CIMP+/MSI+, CIMP+/MSI-, CIMP-/MSI+, and CIMP-/MSI-. There are differences between Western (United States and European Union) and Eastern (Korea and China) populations in the number of CRCs that are MSI+, and in the number of MSI+ CRCs that are CIMP+. Objective.-To review the clinicopathologic and molecular features of the 4 molecular subtypes of CRCs and their precursor lesions, and to emphasize geographic differences in CRCs between Eastern and Western populations. Data Sources.-This article is based on the author's own experimental data and a literature review of relevant articles indexed in PubMed (US National Library of Medicine). Conclusion.-The 4 molecular subtypes of CRC that are defined by their CIMP and MSI statuses are characterized by their own distinct clinicopathologic and molecular features and precursor lesions. In particular, the clinicopathologic features of MSI+ CRCs differ depending on the CIMP status. Further understanding of the heterogeneity in CRC molecular pathways may help to explain the diverse morphologic features of CRCs. (Arch Pathol Lab Med. 2011;135:698-703)
引用
收藏
页码:698 / 703
页数:6
相关论文
共 50 条
  • [31] Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
    Coebergh van den Braak, R. R. J.
    ten Hoorn, S.
    Sieuwerts, A. M.
    Tuynman, J. B.
    Smid, M.
    Wilting, S. M.
    Martens, J. W. M.
    Punt, C. J. A.
    Foekens, J. A.
    Medema, J. P.
    IJzermans, J. N. M.
    Vermeulen, L.
    BMC CANCER, 2020, 20 (01)
  • [32] A Detailed Flow Cytometric Analysis of Immune Activity Profiles in Molecular Subtypes of Colorectal Cancer
    Li, Xingru
    Ling, Agnes
    Kellgren, Therese G.
    Lundholm, Marie
    Lofgren-Burstrom, Anna
    Zingmark, Carl
    Rutegard, Martin
    Ljuslinder, Ingrid
    Palmqvist, Richard
    Edin, Sofia
    CANCERS, 2020, 12 (11) : 1 - 16
  • [33] Molecular genetics of microsatellite-unstable colorectal cancer for pathologists
    Chen, Wei
    Swanson, Benjamin J.
    Frankel, Wendy L.
    DIAGNOSTIC PATHOLOGY, 2017, 12 : 1 - 12
  • [34] Molecular models of carcinogenesis in colorectal cancer
    Zelazowski, Maciej J.
    Bednarek, Andrzej K.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (03): : 181 - 188
  • [35] Molecular pathological classification of colorectal cancer
    Muller, Mike F.
    Ibrahim, Ashraf E. K.
    Arends, Mark J.
    VIRCHOWS ARCHIV, 2016, 469 (02) : 125 - 134
  • [36] Current and future molecular diagnostics in colorectal cancer and colorectal adenoma
    Tsang, Andy Hin-Fung
    Cheng, Ka-Ho
    Wong, Apple Siu-Ping
    Ng, Simon Siu-Man
    Ma, Brigette Buig-Yue
    Chan, Charles Ming-Lok
    Tsui, Nancy Bo-Yin
    Chan, Lawrence Wing-Chi
    Yung, Benjamin Yat-Ming
    Wong, Sze-Chuen Cesar
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) : 3847 - 3857
  • [37] The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer
    Ros, Javier
    Baraibar, Iosune
    Martini, Giulia
    Salva, Francesc
    Saoudi, Nadia
    Luis Cuadra-Urteaga, Jose
    Dienstmann, Rodrigo
    Tabernero, Josep
    Elez, Elena
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (12)
  • [38] Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
    Valenzuela, Guillermo
    Canepa, Joaquin
    Simonetti, Carolina
    Solo de Zaldivar, Loreto
    Marcelain, Katherine
    Gonzalez-Montero, Jaime
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11): : 1000 - 1008
  • [39] Colorectal Cancer Heterogeneity and Targeted Therapy: A Case for Molecular Disease Subtypes
    Linnekamp, Janneke F.
    Wang, Xin
    Medema, Jan Paul
    Vermeulen, Louis
    CANCER RESEARCH, 2015, 75 (02) : 245 - 249
  • [40] Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer
    Wlodarczyk, Marcin
    Wlodarczyk, Jakub
    Siwinski, Pawel
    Sobolewska-Wlodarczyk, Aleksandra
    Fichna, Jakub
    CURRENT DRUG TARGETS, 2018, 19 (15) : 1731 - 1737